These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2591174)

  • 1. Antibiotic resistance in Australia with special reference to sulbactam/ampicillin.
    Fernandes CJ; Ackerman VP
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):153S-157S. PubMed ID: 2591174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of resistance to anaerobic organisms in Australia.
    Munro R
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):159S-163S. PubMed ID: 2591175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactamase production and the role of ampicillin/sulbactam.
    Alpuche-Aranda CM
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
    [No Abstract]   [Full Text] [Related]  

  • 5. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam.
    Pfaller MA; Barry AL; Fuchs PC; Gerlach EH; Hardy DJ; McLaughlin JC
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):356-62. PubMed ID: 8354303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli resistant to ampicillin/sulbactam.
    Eng RH; Yen K; Smith SM; Citron DM; Goldstein EJ; Greenberg R; Cherubin CE
    Chemotherapy; 1992; 38(6):399-404. PubMed ID: 1288964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.
    Varaldo PE; Ripa S; Nicoletti G; Covelli I; Satta G; Carlone N; Fontana R
    Chemotherapy; 1990; 36(2):141-6. PubMed ID: 2178890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the resistance induction in enteric flora in children caused by oral ampicillin plus sulbactam.
    Soylu A; Sanlidag T; Türkmen M; Cakir N; Kavukçu S
    J Antimicrob Chemother; 1997 Jun; 39(6):833-5. PubMed ID: 9222058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ampicillin/sulbactam versus clindamycin in the treatment of postpartum endomyometritis.
    Martens MG; Faro S; Hammill HA; Smith D; Riddle G; Maccato M
    South Med J; 1990 Apr; 83(4):408-13. PubMed ID: 2181689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
    Gill CJ; Ponticas S; Shungu DL; Guerriero S
    Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
    González C; García A; Urrea R; del Solar E; Bello H; Zemelman R
    Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ampicillin/sulbactam: current status in severe bacterial infections.
    Rafailidis PI; Ioannidou EN; Falagas ME
    Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S; Marre R
    Infection; 1991; 19(2):106-9. PubMed ID: 1646771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-lactamase distribution among pathogenic microorganisms. The antibacterial action of a combined preparation of ampicillin/sulbactam (Unasyn)].
    Akar ZhF
    Antibiot Khimioter; 1991 Jun; 36(6):5-8. PubMed ID: 1898192
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of beta-lactamase inhibitor sulbactam plus ampicillin against animal isolates of Pasteurella, Haemophilus, and Staphylococcus.
    Girard AE; Schelkly WU; Murphy KT; Sawyer PS
    Am J Vet Res; 1987 Dec; 48(12):1678-83. PubMed ID: 3501686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current role of penicillin antibiotics: focused on sulbactam sodium/ampicillin sodium. Discussion].
    Jpn J Antibiot; 1994 Nov; 47(11):1421-32. PubMed ID: 7853672
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms.
    Leone F; Morandotti MG; Mazzella P; Sanna A; Ravizzola G; Colombrita D; Pinzi G; Turano R; Menozzi MG; Lecchini R
    J Int Med Res; 1990; 18(3):191-200. PubMed ID: 2193834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of drug resistance in Mycobacterium leprae by ampicillin/sulbactam.
    Prabhakaran K; Harris EB; Randhawa B; Hastings RC
    Microbios; 1992; 72(291):137-42. PubMed ID: 1287401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.